Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Activation of JNK signaling mediates amyloid-ß-dependent cell death 2011-09-14
  2. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease 2006-05-01
  3. Therapeutic promise of JNK ATP-noncompetitive inhibitors 2005-05-01

Studies

3 studies carry this tag.

Date range

2005 to 2011

Top journals

  • Journal of neuropathology and experimental neurology 1
  • PloS one 1
  • Trends in molecular medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Activation of JNK signaling mediates amyloid-ß-dependent cell death

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. PloS one 2011-09-14 Brain scans and imaging

    Our data suggests that (i) accumulation of Aß42 plaques induces JNK signaling in neurons and (ii) induction of JNK contributes to Aß42 mediated cell death.

  2. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuropathology and experimental neurology 2006-05-01 Drug development

    The mitogen-activated protein (MAP) kinase SAPK/JNK phosphorylates tau protein at many of its proline-directed serine/threonine residues in vitro and is a likely candidate kinase to phosphorylate the pathologically relevant S422 site on tau.

  3. Therapeutic promise of JNK ATP-noncompetitive inhibitors

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Trends in molecular medicine 2005-05-01 Risk factors

    Protein kinases are being increasingly targeted in the quest for new therapeutics, and the c-Jun N-terminal kinases (JNKs) are no exception.

All topic tags with their study counts